Raul Cordoba, MD, PhD #WCLLD24
@drraulcordoba
Lymphoma Unit @Hospital_FJD. Board member @sehh_es & @EHA_Hematology. Chair SWG “Aging and Hematology”. @ASH_hematology IMC member
ID: 1697360292
https://www.fjd.es/es/cuadro-medico/raul-cordoba-mascunano 24-08-2013 20:41:53
42,42K Tweet
10,10K Takipçi
4,4K Takip Edilen
In this #JACCCardioOnc review, Dr. David Gent, et al cover the breadth of what is known about #CVD in the adult #HCT population, focusing on acute & late complications, risk prediction, surveillance, & treatment of complications. bit.ly/3ZeW97w #CardioOnc
CONGRESS | #SOHO2024 William Wierda, MD Anderson Cancer Center, presents post hoc exploratory analysis results of the phase I/II TRANSCEND CLL 004 study evaluating characteristics associated with response to liso-cel in pts with R/R CLL/SLL (n=87). OR and CR rates did not correlate with
CONGRESS | #SOHO2024 William Wierda, MD Anderson Cancer Center, discusses whether continuous therapy is the best option for high-risk pts with CLL. In pts with del(17p)/TP53 mutations, second generation covalent BTK inhibitors (such as ibrutinib) show median PFS of 6+ years, however, are
Inspiring talk at European Hematology Association #CRTH2024 by Sirpa Leppa on behalf of the Nordic #Lymphoma Group sharing with scholars 👩🏻🎓🧑🎓 the best example of collaboration among centers in Nordic countries 🇫🇮🇸🇪🇳🇴🇩🇰 to do research 🔬🩺🧬🧫🧪
Incredibly grateful for being part of this experience. Best group to work with! Yasmina Serroukh Tanya Skrypets Tomáš Kříž Rachael Pocock Raul Cordoba, MD, PhD #WCLLD24 European Hematology Association YoungEHA #CRTH2024
European Hematology Association #CRTH2024 course is coming to end soon. Warm congratulations to all scolars, it has been a great journey, well done, all of you ❤️.
#CRTH2024 has come to its end. Amazing scholars, high expertise faculty, extraordinary organization. Thanks to European Hematology Association for this outstanding #mentoring experience. Proud to be part of it. Looking forward to next year edition. Please, apply!! ehaweb.org/research/resea…
Clinical Research Training in Hematology #CRTH European Hematology Association What a transformative experience!!! Difficult to describe! Finalising 9 months of training with a lot of knowledge, new friends and a sharpened perspective! Highly recommended for those who want to achieve big things!
The call is still open!!! Don’t miss the chance to become one of the 2025 #CRTH scholars, learn from leaders in the field of Hematology & experient statisticians. Connect with young hematologists from all over Europe. Take your medical career to the next level 🚀 European Hematology Association
Thanks to European Hematology Association for this year’s #CRTH2024 Amazing organization, true #mentoring from faculty, amazing places in Europe and outstanding supporting scholars, this is a combination I couldn’t even imagine before.
¡¡Ya han pasado 1️⃣0️⃣ años desde que llegué a Fundación Jiménez Díaz!! Buen momento para hacer balance, ¿no creéis?
CONGRESS | #SOHO2024 | POSTER Arnon P. Kater Amsterdam UMC shared early results of the EPCORE CLL-1 trial of epcortitamab in Richter's transformation (RT). N=38, mFU=12.9 mo, ORR was 53% (60% & 44% in 1L RT & 2L RT, resp), CR rate was 42% (50% & 33% in 1L RT & 2L RT, resp), mOS